These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2564376)

  • 41. Quantitative fluorescent immunoassay of antibodies to, and surface antigens of, Actinomyces viscosus.
    Gillis TP; Thompson JJ
    J Clin Microbiol; 1978 Feb; 7(2):202-8. PubMed ID: 344340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement activation by individual and combinations of monoclonal antibodies to Actinomyces viscosus T14V fimbriae: a probe for epitope distribution on these polymeric proteins.
    Sandberg AL; Cisar JO; Siraganian RP; Mudrick LL; Armstrong MW
    Mol Immunol; 1990 Aug; 27(8):787-94. PubMed ID: 1698258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The study of actinomyces viscosus adhere to teeth. III. The identification of mutants of A. viscosus and preparation of rabbit IgG against type 1 and type 2 fimbriae].
    Zhao L; Liu T; Yue S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Feb; 15(1):55-7. PubMed ID: 11480062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies with fimbrial F1C, F12, F13, and F14 specificities obtained with fimbriae from E. coli 04:K12:H-.
    Abe C; Schmitz S; Moser I; Boulnois G; High NJ; Orskov I; Orskov F; Jann B; Jann K
    Microb Pathog; 1987 Jan; 2(1):71-7. PubMed ID: 2907081
    [No Abstract]   [Full Text] [Related]  

  • 45. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae.
    Clark WB; Wheeler TT; Cisar JO
    Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strains of Actinomyces naeslundii and Actinomyces viscosus exhibit structurally variant fimbrial subunit proteins and bind to different peptide motifs in salivary proteins.
    Li T; Johansson I; Hay DI; Strömberg N
    Infect Immun; 1999 May; 67(5):2053-9. PubMed ID: 10225854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of strains of bacteria designated Actinomyces viscosus and Actinomyces naeslundii.
    Fillery ED; Bowden GH; Hardie JM
    Caries Res; 1978; 12(6):299-312. PubMed ID: 282008
    [No Abstract]   [Full Text] [Related]  

  • 48. Immuno-electron microscopic study of antigenic surface components of Actinomyces naeslundii in human dental plaque.
    Garant PR; Cho MI; Iacono V; Shemaka GJ
    Arch Oral Biol; 1979; 24(5):369-77. PubMed ID: 391192
    [No Abstract]   [Full Text] [Related]  

  • 49. Modification of surface composition of Actinomyces viscosus T14V and T14AV.
    Powell JT; Fischlschweiger W; Birdsell DC
    Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphological, chemical and antigenic characterization of M-1 N-acetylmuramidase-digested cell walls of the oral pathogenic bacterium Actinomyces viscosus T14V and T14AV.
    Brown DA; Fischlschweiger W; Birdsell DC
    Arch Oral Biol; 1982; 27(3):183-91. PubMed ID: 6953934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunocytochemical analysis of P-fimbrial structure: localization of minor subunits and the influence of the minor subunit FsoE on the biogenesis of the adhesin.
    Riegman N; Hoschützky H; van Die I; Hoekstra W; Jann K; Bergmans H
    Mol Microbiol; 1990 Jul; 4(7):1193-8. PubMed ID: 1978223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel antigens of oral Actinomyces species prepared from a cell wall enzyme lysate.
    Hamada S; Okahashi N; Kimura S; Imanishi H; Koga T; Kawata S; Michalek SM; McGhee JR
    Jpn J Med Sci Biol; 1982 Aug; 35(4):171-81. PubMed ID: 7154407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A study on biological properties of fimbriae of Actinomyces viscosus. II. Chemical characteristics of fimbriae of A. viscosus].
    Li W; Liu T; Zhang C; Yue S; Zhao C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 May; 17(2):166-8. PubMed ID: 12539717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dominant cross-reactive antibodies generated during the response to a variety of oral bacterial species detect phosphorylcholine.
    Gmür R; Thurnheer T; Guggenheim B
    J Dent Res; 1999 Jan; 78(1):77-85. PubMed ID: 10065949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Actinomyces georgiae sp. nov., Actinomyces gerencseriae sp. nov., designation of two genospecies of Actinomyces naeslundii, and inclusion of A. naeslundii serotypes II and III and Actinomyces viscosus serotype II in A. naeslundii genospecies 2.
    Johnson JL; Moore LV; Kaneko B; Moore WE
    Int J Syst Bacteriol; 1990 Jul; 40(3):273-86. PubMed ID: 2397195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.
    Li ZM; Brennan MJ; David JL; Carter PH; Cowell JL; Manclark CR
    Infect Immun; 1988 Dec; 56(12):3184-8. PubMed ID: 2903125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct detection of cell surface interactive forces of sessile, fimbriated and non-fimbriated Actinomyces spp. using atomic force microscopy.
    Tang G; Yip HK; Samaranayake LP; Chan KY; Luo G; Fang HH
    Arch Oral Biol; 2004 Sep; 49(9):727-38. PubMed ID: 15275860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hemagglutination pattern and the distribution of pili antigen among clinically isolated strains of Serratia marcescens].
    Amako K; Kohno K
    Kansenshogaku Zasshi; 1982 Jul; 56(7):560-5. PubMed ID: 6130118
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of novel oligonucleotide probes for seven Actinomyces species and their utility in supragingival plaque analysis.
    Tang G; Yip HK; Luo G; Cheung BP; Shen S; Samaranayake LP
    Oral Dis; 2003 Jul; 9(4):203-9. PubMed ID: 12974520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies that bind to fimbriae block adhesion of Streptococcus sanguis to saliva-coated hydroxyapatite.
    Fachon-Kalweit S; Elder BL; Fives-Taylor P
    Infect Immun; 1985 Jun; 48(3):617-24. PubMed ID: 2860066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.